Premium
Inhibitor binding alters the directions of domain motions in HIV‐1 reverse transcriptase
Author(s) -
Temiz N. Alpay,
Bahar Ivet
Publication year - 2002
Publication title -
proteins: structure, function, and bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.699
H-Index - 191
eISSN - 1097-0134
pISSN - 0887-3585
DOI - 10.1002/prot.10183
Subject(s) - reverse transcriptase , efavirenz , rnase h , nevirapine , molecular dynamics , chemistry , hinge , biophysics , flexibility (engineering) , domain (mathematical analysis) , human immunodeficiency virus (hiv) , computational biology , biology , rna , physics , virology , biochemistry , computational chemistry , antiretroviral therapy , mathematics , classical mechanics , viral load , gene , statistics , mathematical analysis
Abstract Understanding the molecular mechanisms of HIV‐1 reverse transcriptase (RT) action and drug inhibition is essential for designing effective antiretroviral therapies. Although comparisons of the different crystal forms of RT give insights into the flexibility of different domains, a direct computational assessment of the effect of inhibitor binding on the collective dynamics of RT is lacking. A structure‐based approach is used here for exploring the dynamics of RT in unliganded and inhibitor‐bound forms. Non‐nucleoside RT inhibitors (NNRTI) are shown to interfere directly with the global hinge‐bending mechanism that controls the cooperative motions of the p66 fingers and thumb subdomains. The net effect of nevirapine binding is to change the direction of domain movements rather than suppress their mobilities. The second generation NNRTI, efavirenz, on the other hand, shows the stronger effect of simultaneously reorienting domain motions and obstructing the p66 thumb fluctuations. A second hinge site controlling the global rotational reorientations of the RNase H domain is identified, which could serve as a target for potential inhibitors of RNase H activity. Proteins 2002;49:61–70. © 2002 Wiley‐Liss, Inc.